CD163 and neoplasm: In contrast, CD163-positive tumor cells were found in 62 % of samples, of which 36 cases (Fig. 2 d1, d2, d3) and 43 cases (Fig. 2 b1, b2, b3) have increased and decreased expression of CD163.